Document Detail

High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report.
MedLine Citation:
PMID:  11038466     Owner:  NLM     Status:  MEDLINE    
Abnormal amniotic fluid volume can be associated with increased maternal risk as well as perinatal morbidity and mortality. Polyhydramnios is often indicative of fetal, placental or maternal problems. In a large proportion of patients the aetiology of the disorder is unclear. Here we report on a case in which numerous fetal erythroblasts and large quantities of extracellular fetal DNA were found in the peripheral blood of a pregnant woman with idiopathic polyhydramnios bearing a male fetus. Following enrichment of erythroblasts by magnetic separation (MACS) and anti-CD71 antibodies, approximately 45-fold more erythroblasts were determined per ml peripheral maternal blood than in matched controls (231 versus 5). Single cell multiplex polymerase chain reaction (PCR) of individually micromanipulated erythroblasts showed that approximately 122 of these were of fetal origin. The concentration of extracellular fetal circulatory DNA in maternal plasma was determined by real-time quantitative PCR and shown to be almost double that of the control group (749.2 versus 404 fetal genome equivalents per ml maternal plasma). It can be speculated that the increased intrauterine pressure in polyhydramnios leads to an enhanced influx of fetal cells and free extracellular fetal DNA into the maternal circulation. This hypothesis will have to be tested with further cases.
X Y Zhong; W Holzgreve; J C Li; K Aydinli; S Hahn
Related Documents :
6319906 - An investigation into opioid systems in the pregnant rat.
911716 - Plasma oestriol and placental proteins: a cross-sectional study at 38 weeks gestation.
10796166 - Plasma volume expansion for suspected impaired fetal growth.
6652176 - Changes in the concentrations of corticosteroids in the blood of fetal pigs and their d...
21564406 - Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
3067166 - The diagnosis of altered fetal growth.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  20     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-11-08     Completed Date:  2000-12-28     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  838-41     Citation Subset:  IM    
Copyright Information:
Copyright 2000 John Wiley & Sons, Ltd.
Laboratory for Prenatal Medicine, Department of Obstetrics and Gynaecology, University of Basel, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
DNA / blood,  genetics*
DNA Primers
Fetal Blood / cytology
Infant, Newborn
Polyhydramnios / blood*,  physiopathology*
Polymerase Chain Reaction
Grant Support
Reg. No./Substance:
0/DNA Primers; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sonographic and molecular diagnosis of thanatophoric dysplasia type I at 18 weeks of gestation.
Next Document:  Incidental prenatal detection of an Xp deletion using an anonymous primer pair for fetal sexing.